HPSI0516i-suqd_6

General

Cell Line

hPSCreg name WTSIi609-B
Cite as:
WTSIi609-B (RRID:CVCL_LF06)
Alternative name(s)
HPSI0516i-suqd_6
Cell line type Human induced pluripotent stem cell (hiPSC)
Similar lines
WTSIi609-A
(HPSI0516i-suqd_3)
Donor diseases:
Rare hypertrophic cardiomyopathy
WTSIi508-B
(HPSI0416i-jewl_6)
Donor diseases:
Rare hypertrophic cardiomyopathy
WTSIi466-B
(HPSI0416i-aicq_4)
Donor diseases:
Rare hypertrophic cardiomyopathy
WTSIi483-B
(HPSI0416i-ourj_2)
Donor diseases:
Rare hypertrophic cardiomyopathy
WTSIi484-B
(HPSI0716i-bakv_4)
Donor diseases:
Rare hypertrophic cardiomyopathy
WTSIi689-A
(HPSI0616i-newl_6)
Donor diseases:
Rare hypertrophic cardiomyopathy
WTSIi466-A
(HPSI0416i-aicq_1)
Donor diseases:
Rare hypertrophic cardiomyopathy
WTSIi483-A
(HPSI0416i-ourj_1)
Donor diseases:
Rare hypertrophic cardiomyopathy
WTSIi484-A
(HPSI0716i-bakv_6)
Donor diseases:
Rare hypertrophic cardiomyopathy
WTSIi508-A
(HPSI0416i-jewl_5)
Donor diseases:
Rare hypertrophic cardiomyopathy
ICANi001-A-1
(CDGEN1.16.40.5)
Donor diseases:
hypertrophic cardiomyopathy
UKEi070-A-1
(Rep 28, Iso Co)
Donor diseases:
hypertrophic cardiomyopathy
UKEi070-A-2
(Bi-allelic mutant, Mut 103)
Donor diseases:
hypertrophic cardiomyopathy
CIRMi893-A
(CW30205)
Donor diseases:
Hypertrophic Cardiomyopathy
SCVIi036-A
(SCVI248)
Donor diseases:
hypertrophic cardiomyopathy
SCVIi037-A
(SCVI672)
Donor diseases:
hypertrophic cardiomyopathy
CIRMi909-A
(CW30224)
Donor diseases:
Hypertrophic Cardiomyopathy
CIRMi919-A
(CW30234)
Donor diseases:
Hypertrophic Cardiomyopathy
ZJUi011-A
(ZJULLi003-A, LSYMYH7iPS)
Donor diseases:
Hypertrophic cardiomyopathy
CIRMi920-A
(CW30235)
Donor diseases:
Hypertrophic Cardiomyopathy
ZJUi012-A
(ZJULLi004-A, ZYLMYBPC3iPS)
Donor diseases:
Hypertrophic cardiomyopathy
CIRMi937-A
(CW30256)
Donor diseases:
Hypertrophic Cardiomyopathy
UKKi035-A
(NP0139-A, NP0139-3E)
Donor's gene variants:
MYBPC3, MYBPC3
Donor diseases:
Rare hypertrophic cardiomyopathy
CIRMi947-A
(CW30266)
Donor diseases:
Hypertrophic Cardiomyopathy
UKKi035-B
(NP0139-B, NP0139-6C)
Donor's gene variants:
MYBPC3, MYBPC3
Donor diseases:
Rare hypertrophic cardiomyopathy
UKKi035-C
(NP0139-C, NP0139-24D)
Donor's gene variants:
MYBPC3, MYBPC3
Donor diseases:
Rare hypertrophic cardiomyopathy
WTSIi679-B
(HPSI0316i-ponl_4)
Donor diseases:
Rare hypertrophic cardiomyopathy
WTSIi685-B
(HPSI0416i-ioys_6)
Donor diseases:
Rare hypertrophic cardiomyopathy
WTSIi493-B
(HPSI0416i-ruah_5)
Donor diseases:
Rare hypertrophic cardiomyopathy
CIRMi969-A
(CW30292)
Donor diseases:
Hypertrophic Cardiomyopathy
CIRMi970-A
(CW30293)
Donor diseases:
Hypertrophic Cardiomyopathy
CIRMi971-A
(CW30295)
Donor diseases:
Hypertrophic Cardiomyopathy
WTSIi460-B
(HPSI0516i-jepf_3)
Donor diseases:
Rare hypertrophic cardiomyopathy
IBBISTi005-A
(F81 (940) clone 5)
Donor diseases:
Hypertrophic Cardiomyopathy
IBBISTi005-B
(F81 (940) clone 8)
Donor diseases:
Hypertrophic Cardiomyopathy
CIRMi982-A
(CW30310)
Donor diseases:
Hypertrophic Cardiomyopathy
CIRMi983-A
(CW30311)
Donor diseases:
Hypertrophic Cardiomyopathy
CIRMi984-A
(CW30312)
Donor diseases:
Hypertrophic Cardiomyopathy
CIRMi985-A
(CW30314)
Donor diseases:
Hypertrophic Cardiomyopathy
SCVIi096-A
(SCVI-675fs1)
Donor diseases:
Hypertrophic Cardiomyopathy
SCVIi097-A
(SCVI-675fs2)
Donor diseases:
Hypertrophic Cardiomyopathy
SCVIi098-A
(SCVI-675fs3)
Donor diseases:
Hypertrophic Cardiomyopathy
SCVIi099-A
(SCVI-675fs4)
Donor diseases:
Hypertrophic Cardiomyopathy
CIRMi999-A
(CW30329)
Donor diseases:
Hypertrophic Cardiomyopathy
CIRMi00A-A
(CW30331)
Donor diseases:
Hypertrophic Cardiomyopathy
WTSIi679-A
(HPSI0316i-ponl_2)
Donor diseases:
Rare hypertrophic cardiomyopathy
CIRMi746-A
(CW30024)
Donor diseases:
Hypertrophic Cardiomyopathy
Last update 6th October 2021
User feedback
No feedback available yet.

Login to share your feedback, experiences or results with the research community.

Provider

Generator Wellcome Sanger Institute (WTSI)
Distributors

External Databases

BioSamples SAMEA4861168
HipSci HPSI0516i-suqd_6
Cellosaurus CVCL_LF06
Wikidata Q54890981

General Information

Projects
* Is the cell line readily obtainable for third parties?
Yes
Research use: allowed
Clinical use: not allowed
Commercial use: not allowed

Donor Information

General Donor Information

Sex male
Age of donor (at collection) 30-34
Ethnicity Caucasian

Phenotype and Disease related information (Donor)

Diseases A disease was diagnosed.

Donor Relations

Other cell lines of this donor

External Databases (Donor)

BioSamples SAMEA4452341

Ethics

Has informed consent been obtained from the donor of the embryo/tissue from which the pluripotent stem cells have been derived? Yes
Was the consent voluntarily given? Yes
Has the donor been informed that participation will not directly influence their personal treatment? Yes
Can you provide us with a copy of the Donor Information Sheet provided to the donor? Yes
Do you (Depositor/Provider) hold the original Donor Consent Form? No
If you do not hold the Donor Consent Form, do you know who does? No
Please indicate whether the data associated with the donated material has been pseudonymised or anonymised. pseudonymised
Does consent explicitly allow the derivation of pluripotent stem cells? Yes
Does consent expressly prevent the derivation of pluripotent stem cells? No
Does consent prevent CELLS DERIVED FROM THE DONATED BIOSAMPLE from being made available to researchers anywhere in the world? No
How may genetic information associated with the cell line be accessed?
Will the donor expect to receive financial benefit, beyond reasonable expenses, in return for donating the biosample? No
Has a favourable opinion been obtained from a research ethics committee, or other ethics review panel, in relation to the Research Protocol including the consent provisions? No
Has a favourable opinion been obtained from a research ethics committee, or other ethics review panel, in relation to the PROPOSED PROJECT, involving use of donated embryo/tissue or derived cells? Yes
Name of accrediting authority involved? Hampstead Research Ethics Committee
Approval number 13/LO/0171
For generation of the cell line, who was the supplier of any recombined DNA vectors or commercial kits used?

hIPSC Derivation

General

Source cell type
A leukocyte with a single non-segmented nucleus in the mature form.
Synonyms
  • mononuclear leukocyte
  • peripheral blood mononuclear cell
Source cell origin
A fluid that is composed of blood plasma and erythrocytes.
Synonyms
  • portion of blood
  • vertebrate blood
  • whole blood
Age of donor (at collection) 30-34
Collected in 2016
Source cell line vendor University College London

Reprogramming method

Vector type Non-integrating
Vector Sendai virus
Notes on reprogramming vector detection CytoTune 2

Vector free reprogramming

Other

Derived under xeno-free conditions
Unknown
Derived under GMP?
Unknown
Available as clinical grade?
Unknown

Culture Conditions

Surface coating Vitronectin
Feeder cells
No
Passage method Enzyme-free cell dissociation
EDTA
CO2 Concentration 5 %
Medium TeSR™ E8™

Characterisation

Analysis of Undifferentiated Cells
Pluripotency Score Novelty Score
19.998 1.387

Certificate of Analysis

Is there a certificate of analysis available?
Yes
Passage:

Genotyping

Karyotyping (Cell Line)

Has the cell line karyotype been analysed?
No

Other Genotyping (Cell Line)

Is there genome-wide genotyping or functional data available?
Yes